| Style | Citing Format |
|---|---|
| MLA | Aghdam KA, et al.. "Hemifield-Slide Diplopia Successfully Managed With Botulinum Toxin Injection in a Patient With Traumatic Chiasmal Disruption." Clinical and Experimental Optometry, vol. 105, no. 4, 2022, pp. 445-447. |
| APA | Aghdam KA, Aghajani A, Rahbarian FH, Sanjari MS (2022). Hemifield-Slide Diplopia Successfully Managed With Botulinum Toxin Injection in a Patient With Traumatic Chiasmal Disruption. Clinical and Experimental Optometry, 105(4), 445-447. |
| Chicago | Aghdam KA, Aghajani A, Rahbarian FH, Sanjari MS. "Hemifield-Slide Diplopia Successfully Managed With Botulinum Toxin Injection in a Patient With Traumatic Chiasmal Disruption." Clinical and Experimental Optometry 105, no. 4 (2022): 445-447. |
| Harvard | Aghdam KA et al. (2022) 'Hemifield-Slide Diplopia Successfully Managed With Botulinum Toxin Injection in a Patient With Traumatic Chiasmal Disruption', Clinical and Experimental Optometry, 105(4), pp. 445-447. |
| Vancouver | Aghdam KA, Aghajani A, Rahbarian FH, Sanjari MS. Hemifield-Slide Diplopia Successfully Managed With Botulinum Toxin Injection in a Patient With Traumatic Chiasmal Disruption. Clinical and Experimental Optometry. 2022;105(4):445-447. |
| BibTex | @article{ author = {Aghdam KA and Aghajani A and Rahbarian FH and Sanjari MS}, title = {Hemifield-Slide Diplopia Successfully Managed With Botulinum Toxin Injection in a Patient With Traumatic Chiasmal Disruption}, journal = {Clinical and Experimental Optometry}, volume = {105}, number = {4}, pages = {445-447}, year = {2022} } |
| RIS | TY - JOUR AU - Aghdam KA AU - Aghajani A AU - Rahbarian FH AU - Sanjari MS TI - Hemifield-Slide Diplopia Successfully Managed With Botulinum Toxin Injection in a Patient With Traumatic Chiasmal Disruption JO - Clinical and Experimental Optometry VL - 105 IS - 4 SP - 445 EP - 447 PY - 2022 ER - |